Cargando…
The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction
AIMS: Mouse models with genetic modifications are required to investigate atherogenesis and associated metabolic syndrome. Adeno-associated virus-8 (AAV8)-mediated overexpression of PCSK9 (AAV8-PCSK9) induces hyperlipidaemia and promotes atherosclerosis in C57BL/6 mice. We aimed to assess whether AA...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242032/ https://www.ncbi.nlm.nih.gov/pubmed/35919346 http://dx.doi.org/10.1093/ehjopen/oeac028 |
_version_ | 1784737965309689856 |
---|---|
author | Keeter, William Coles Carter, Nigeste M Nadler, Jerry L Galkina, Elena V |
author_facet | Keeter, William Coles Carter, Nigeste M Nadler, Jerry L Galkina, Elena V |
author_sort | Keeter, William Coles |
collection | PubMed |
description | AIMS: Mouse models with genetic modifications are required to investigate atherogenesis and associated metabolic syndrome. Adeno-associated virus-8 (AAV8)-mediated overexpression of PCSK9 (AAV8-PCSK9) induces hyperlipidaemia and promotes atherosclerosis in C57BL/6 mice. We aimed to assess whether AAV8-PCSK9-injected C57BL/6 mice fed high-fat diet with added cholesterol (HFD-C) would serve as a model of combined metabolic syndrome and atherosclerosis. METHODS AND RESULTS: C57BL/6 mice received i.v. injection of AAV-PCSK9 and sex- and age-matched Ldlr(−/−) and C57BL/6 control mice were placed on HFD-C or chow diet for 20 weeks (B6-PCSK9-HFD-C, Ldlr(−/−) HFD-C, B6-HFD-C, and B6-Chow, respectively). High-fat diet with added cholesterol feeding led to insulin resistance and impaired glucose clearance in B6-PCSK9-HFD-C mice compared with B6-Chow controls. This decrease in metabolic health in B6-PCSK9-HFD-C mice as well as the development of atherosclerosis was similar to Ldlr(−/−) HFD-C mice. Importantly, HFD-C feeding induced pancreatic islet hyperplasia in B6-PCSK9-HFD-C and B6-HFD-C compared with B6-Chow controls. In line with alterations in the metabolic phenotype, there was an increase in the number of pro-inflammatory Ly6C(high/med) monocytes within the adipose tissues of B6-PCSK9-HFD-C and B6-HFD-C compared with B6-Chow controls. CONCLUSION: High-fat diet with added cholesterol-fed AAV-PCSK9-injected C57BL/6 mice can serve as a useful model of integrated metabolic syndrome and atherosclerosis that does not require genetic manipulations. |
format | Online Article Text |
id | pubmed-9242032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-92420322022-08-01 The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction Keeter, William Coles Carter, Nigeste M Nadler, Jerry L Galkina, Elena V Eur Heart J Open Short Report AIMS: Mouse models with genetic modifications are required to investigate atherogenesis and associated metabolic syndrome. Adeno-associated virus-8 (AAV8)-mediated overexpression of PCSK9 (AAV8-PCSK9) induces hyperlipidaemia and promotes atherosclerosis in C57BL/6 mice. We aimed to assess whether AAV8-PCSK9-injected C57BL/6 mice fed high-fat diet with added cholesterol (HFD-C) would serve as a model of combined metabolic syndrome and atherosclerosis. METHODS AND RESULTS: C57BL/6 mice received i.v. injection of AAV-PCSK9 and sex- and age-matched Ldlr(−/−) and C57BL/6 control mice were placed on HFD-C or chow diet for 20 weeks (B6-PCSK9-HFD-C, Ldlr(−/−) HFD-C, B6-HFD-C, and B6-Chow, respectively). High-fat diet with added cholesterol feeding led to insulin resistance and impaired glucose clearance in B6-PCSK9-HFD-C mice compared with B6-Chow controls. This decrease in metabolic health in B6-PCSK9-HFD-C mice as well as the development of atherosclerosis was similar to Ldlr(−/−) HFD-C mice. Importantly, HFD-C feeding induced pancreatic islet hyperplasia in B6-PCSK9-HFD-C and B6-HFD-C compared with B6-Chow controls. In line with alterations in the metabolic phenotype, there was an increase in the number of pro-inflammatory Ly6C(high/med) monocytes within the adipose tissues of B6-PCSK9-HFD-C and B6-HFD-C compared with B6-Chow controls. CONCLUSION: High-fat diet with added cholesterol-fed AAV-PCSK9-injected C57BL/6 mice can serve as a useful model of integrated metabolic syndrome and atherosclerosis that does not require genetic manipulations. Oxford University Press 2022-04-20 /pmc/articles/PMC9242032/ /pubmed/35919346 http://dx.doi.org/10.1093/ehjopen/oeac028 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Short Report Keeter, William Coles Carter, Nigeste M Nadler, Jerry L Galkina, Elena V The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction |
title | The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction |
title_full | The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction |
title_fullStr | The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction |
title_full_unstemmed | The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction |
title_short | The AAV-PCSK9 murine model of atherosclerosis and metabolic dysfunction |
title_sort | aav-pcsk9 murine model of atherosclerosis and metabolic dysfunction |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242032/ https://www.ncbi.nlm.nih.gov/pubmed/35919346 http://dx.doi.org/10.1093/ehjopen/oeac028 |
work_keys_str_mv | AT keeterwilliamcoles theaavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction AT carternigestem theaavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction AT nadlerjerryl theaavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction AT galkinaelenav theaavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction AT keeterwilliamcoles aavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction AT carternigestem aavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction AT nadlerjerryl aavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction AT galkinaelenav aavpcsk9murinemodelofatherosclerosisandmetabolicdysfunction |